Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-26

FDA Approved: LOVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for lovastatin, authorizing changes requested in the application (such as labeling or manufactu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lovastatin (Lovastatin)

Snippet

SUPPL AP for LOVASTATIN (LOVASTATIN)